

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding and managing gout | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-247/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-247" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding and managing gout" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding and managing gout.">
            <meta name="og:description" content="Read the latest article version by Talia F. Igel, Svetlana Krasnokutsky, Michael H. Pillinger, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="10126">
            <meta name="article-id" content="9402">
            <meta name="dc.title" content="Recent advances in understanding and managing gout">
            <meta name="dc.description" content="Gout is the most common crystal arthropathy and the leading cause of inflammatory arthritis. It is associated with functional impairment and, for many, a diminished health-related quality of life. Numerous studies have demonstrated the impact of gout and its associated conditions on patient morbidity and mortality. Unfortunately, gout remains under-diagnosed and under-treated in the general community. Despite major advances in treatment strategies, as many as 90% of patients with gout are poorly controlled or improperly managed and their hyperuricemia and recurrent flares continue. The introduction of novel urate-lowering therapies, new imaging modalities, and a deeper understanding of the pathogenesis of gout raise the possibility of better gout care and improved patient outcomes. Here, we spotlight recent advances in the diagnosis and management of gout and discuss novel therapeutics in gout treatment.">
            <meta name="dc.subject" content="gout, urate-lowering therapy, gout treatment">
            <meta name="dc.creator" content="Igel, Talia F.">
            <meta name="dc.creator" content="Krasnokutsky, Svetlana">
            <meta name="dc.creator" content="Pillinger, Michael H.">
            <meta name="dc.date" content="2017/03/10">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.9402.1">
            <meta name="dc.source" content="F1000Research 2017 6:247">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="gout">
            <meta name="prism.keyword" content="urate-lowering therapy">
            <meta name="prism.keyword" content="gout treatment">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/03/10">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="247">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.9402.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-247">
            <meta name="citation_title" content="Recent advances in understanding and managing gout">
            <meta name="citation_abstract" content="Gout is the most common crystal arthropathy and the leading cause of inflammatory arthritis. It is associated with functional impairment and, for many, a diminished health-related quality of life. Numerous studies have demonstrated the impact of gout and its associated conditions on patient morbidity and mortality. Unfortunately, gout remains under-diagnosed and under-treated in the general community. Despite major advances in treatment strategies, as many as 90% of patients with gout are poorly controlled or improperly managed and their hyperuricemia and recurrent flares continue. The introduction of novel urate-lowering therapies, new imaging modalities, and a deeper understanding of the pathogenesis of gout raise the possibility of better gout care and improved patient outcomes. Here, we spotlight recent advances in the diagnosis and management of gout and discuss novel therapeutics in gout treatment.">
            <meta name="citation_description" content="Gout is the most common crystal arthropathy and the leading cause of inflammatory arthritis. It is associated with functional impairment and, for many, a diminished health-related quality of life. Numerous studies have demonstrated the impact of gout and its associated conditions on patient morbidity and mortality. Unfortunately, gout remains under-diagnosed and under-treated in the general community. Despite major advances in treatment strategies, as many as 90% of patients with gout are poorly controlled or improperly managed and their hyperuricemia and recurrent flares continue. The introduction of novel urate-lowering therapies, new imaging modalities, and a deeper understanding of the pathogenesis of gout raise the possibility of better gout care and improved patient outcomes. Here, we spotlight recent advances in the diagnosis and management of gout and discuss novel therapeutics in gout treatment.">
            <meta name="citation_keywords" content="gout, urate-lowering therapy, gout treatment">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Talia F. Igel">
            <meta name="citation_author_institution" content="The Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, NY, USA">
            <meta name="citation_author_institution" content="The School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia">
            <meta name="citation_author" content="Svetlana Krasnokutsky">
            <meta name="citation_author_institution" content="The Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, NY, USA">
            <meta name="citation_author" content="Michael H. Pillinger">
            <meta name="citation_author_institution" content="The Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, NY, USA">
            <meta name="citation_publication_date" content="2017/03/10">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="247">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.9402.1">
            <meta name="citation_firstpage" content="247">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-247/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-247.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=10126 /> <input type=hidden id=articleId name=articleId value=9402 /> <input type=hidden id=xmlUrl value="/articles/6-247/v1/xml"/> <input type=hidden id=xmlFileName value="-6-247-v1.xml"> <input type=hidden id=article_uuid value=0eb00956-c4cc-4a59-8189-7cca07973af7 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding and managing gout"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.9402.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.9402.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-247"
  },
  "headline": "Recent advances in understanding and managing gout",
  "datePublished": "2017-03-10T09:31:52",
  "dateModified": "2017-03-10T09:31:52",
  "author": [
    {
      "@type": "Person",
      "name": "Talia F. Igel"
    },    {
      "@type": "Person",
      "name": "Svetlana Krasnokutsky"
    },    {
      "@type": "Person",
      "name": "Michael H. Pillinger"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Gout is the most common crystal arthropathy and the leading cause of inflammatory arthritis. It is associated with functional impairment and, for many, a diminished health-related quality of life. Numerous studies have demonstrated the impact of gout and its associated conditions on patient morbidity and mortality. Unfortunately, gout remains under-diagnosed and under-treated in the general community. Despite major advances in treatment strategies, as many as 90% of patients with gout are poorly controlled or improperly managed and their hyperuricemia and recurrent flares continue. The introduction of novel urate-lowering therapies, new imaging modalities, and a deeper understanding of the pathogenesis of gout raise the possibility of better gout care and improved patient outcomes. Here, we spotlight recent advances in the diagnosis and management of gout and discuss novel therapeutics in gout treatment."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-247/v1",
            "name": "Recent advances in understanding and managing gout"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding and managing gout </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=10126 data-id=9402 data-downloads="" data-views="" data-scholar="10.12688/f1000research.9402.1" data-recommended="" data-doi="10.12688/f1000research.9402.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-247/v1/pdf?article_uuid=0eb00956-c4cc-4a59-8189-7cca07973af7" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-9402-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-9402-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-9402-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Igel TF, Krasnokutsky S and Pillinger MH. Recent advances in understanding and managing gout [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):247 (<a class=new-orange href="https://doi.org/10.12688/f1000research.9402.1" target=_blank>https://doi.org/10.12688/f1000research.9402.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-9402-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=9402 id=track-article-signin-9402 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/9402?target=/articles/6-247/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=10126 /> <input name=articleId type=hidden value=9402 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding and managing gout</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Talia F. Igel<sup>1,2</sup>,&nbsp;</span><span class="">Svetlana Krasnokutsky<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:michael.pillinger@nyumc.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Michael H. Pillinger</span></a><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Talia F. Igel<sup>1,2</sup>,&nbsp;</span><span class="">Svetlana Krasnokutsky<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:michael.pillinger@nyumc.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Michael H. Pillinger</span></a><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 10 Mar 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.9402.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> The Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, NY, USA<br/> <sup>2</sup> The School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=19888-19541></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=19887-19540></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Gout is the most common crystal arthropathy and the leading cause of inflammatory arthritis. It is associated with functional impairment and, for many, a diminished health-related quality of life. Numerous studies have demonstrated the impact of gout and its associated conditions on patient morbidity and mortality. Unfortunately, gout remains under-diagnosed and under-treated in the general community. Despite major advances in treatment strategies, as many as 90% of patients with gout are poorly controlled or improperly managed and their hyperuricemia and recurrent flares continue. The introduction of novel urate-lowering therapies, new imaging modalities, and a deeper understanding of the pathogenesis of gout raise the possibility of better gout care and improved patient outcomes. Here, we spotlight recent advances in the diagnosis and management of gout and discuss novel therapeutics in gout treatment. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> gout, urate-lowering therapy, gout treatment </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Michael H. Pillinger (<a href="mailto:michael.pillinger@nyumc.org">michael.pillinger@nyumc.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Michael H. Pillinger </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> Talia F. Igel declares that she has no competing interests. Svetlana Krasnokutsky has served as a consultant for Crealta, Horizon and Ironwood. Michael H. Pillinger serves or has served as a consultant for AstraZeneca, Crealta, Horizon, Ironwood and Sobi and has been an investigative site for a sponsored trial by Takeda. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> TFI was supported in part by a travel scholarship from Monash University. SK was supported in part by an Investigator Award from the Rheumatology Research Foundation and by a New York State Empire Clinical Research Investigator Program award. MHP receives salary support from NYU CTSA grant 1UL1TR001445 from the National Center for the Advancement of Translational Science, National Institutes of Health. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2017 Igel TF <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Igel TF, Krasnokutsky S and Pillinger MH. Recent advances in understanding and managing gout [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):247 (<a href="https://doi.org/10.12688/f1000research.9402.1" target=_blank>https://doi.org/10.12688/f1000research.9402.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 10 Mar 2017, <b>6</b>(F1000 Faculty Rev):247 (<a href="https://doi.org/10.12688/f1000research.9402.1" target=_blank>https://doi.org/10.12688/f1000research.9402.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 10 Mar 2017, <b>6</b>(F1000 Faculty Rev):247 (<a href="https://doi.org/10.12688/f1000research.9402.1" target=_blank>https://doi.org/10.12688/f1000research.9402.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d25407e210>Introduction</h2><p class="" id=d25407e213>Gout incidence and prevalence have surged in recent years<sup><a href="#ref-1">1</a></sup>, reflecting population risk factors and the cultural transmission of predisposing habits of diet and behavior. Notwithstanding refined management guidelines, multiple effective medications, and improved physician understanding of treatment protocols, too many patients are still not meeting therapeutic goals<sup><a href="#ref-2">2</a></sup>. Fortunately, the rising prevalence of gout has brought a renewed interest in its biology, diagnosis, and treatment. Here, we review some recent advances in gout, including the introduction of novel therapeutics, the role of genetic screening, and the development of new gout classification and management guidelines.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25407e227>New biology: renal handling and the basis of hyperuricemia</h2><p class="" id=d25407e230>Serum urate (sUA) levels are determined by the balance of metabolic production and excretion through the gastrointestinal tract and, most prominently, the kidneys. Among individuals who have primary hyperuricemia (that is, no acquired causes of urate overproduction or chronic kidney disease), upwards of 90% have urate elevation as a consequence of inadequate excretion<sup><a href="#ref-3">3</a></sup>. Recent genetic and physiologic studies have expanded our insight into the mechanisms through which uric acid is transported across the renal tubule<sup><a href="#ref-4">4</a></sup>. Although close to 100% of urate passing through a healthy kidney is filtrated by the glomerulus, only 5% to 10% is actually excreted<sup><a href="#ref-5">5</a></sup>. Among gout patients who are primary underexcreters, this number is even lower, ranging from 3% to 5%<sup><a href="#ref-6">6</a></sup>. The fractional excretion of urate (FEUA) tends to increase in response to rising sUA levels, providing a mechanism for sUA adjustment in response to serum loads. However, FEUA appears to be less responsive to sUA changes at higher sUA ranges and in the setting of primary under-excretion (that is, intrinsically low FEUA). In particular, the renal excretory system of patients with gout may be less responsive to rising sUA levels, reiteratively contributing to the pathogenesis of hyperuricemia<sup><a href="#ref-7">7</a></sup>.</p><p class="" id=d25407e253>Urate handling at the kidney occurs primarily in the proximal convoluted tubule (PCT), where transporters function either to reabsorb (for example, URAT1, OAT4, OAT10, and GLUT9) or secrete (for example, NPT1 and 4, MRP, and OAT1, 2, and 3) uric acid across the tubular endothelium. Among the reabsorbing transporters, URAT1 is central to maintaining sUA levels<sup><a href="#ref-6">6</a></sup>. Patients with deficiencies or inactivating mutations of the URAT1 transporter demonstrate markedly lower sUA levels compared with healthy controls<sup><a href="#ref-8">8</a></sup>, and drugs such as probenecid, losartan, and lesinurad (see Lesinurad section below) lower sUA and increase the fractional excretion of uric acid by inhibiting URAT1. Genome-wide association studies (GWAS) implicate genetic variants in URAT1, OAT4, OAT10, and GLUT9 in the development of hyperuricemia<sup><a href="#ref-9">9</a><a href="#ref-12">12</a></sup>, suggesting the possibility that patients with hyperuricemia have gain-of-function variants of these transporters that promote the retention of uric acid. Some drugs that cause hyperuricemia (for example, pyrazinamide) appear to function by promoting the retentive activity of the pumps, particularly URAT1. On the other hand, though it is less firmly established, GWAS suggest that variants in the secretory uric acid transporters NPT1 and 4, MRP, and OAT13 are also associated with hyperuricemia, presumably implying a loss-of-function state allowing sUA to accumulate.</p><p class="" id=d25407e271>The mechanisms of urate excretion from the intestine have been less well studied but may be of increased importance in patients whose renal excretion of uric acid is impaired. Recent GWAS data have implicated loss-of-function variants in a secretory pump, ABCG2, as a possible cause of hyperuricemia. Although ABCG2 was initially found to be expressed in the renal PCT, more recent studies suggest that it is much more highly expressed in the intestine, possibly providing insight into the mechanisms of gastrointestinal urate excretion<sup><a href="#ref-6">6</a>,<a href="#ref-13">13</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25407e284>New algorithms: diagnosis and classification</h2><p class="" id=d25407e287>Historically, the diagnosis of gout focused on the acute arthritic state and did not consider the potential for chronicity. Proposed classification criteria demonstrated suboptimal sensitivity and specificity, were never validated, or did not incorporate advances in imaging modalities. In 2015, the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) jointly published validated classification criteria that encompass acute and chronic aspects of gout, recent imaging advances, and weighting to maximize sensitivity and specificity<sup><a href="#ref-14">14</a></sup>. These criteria permit improved enrollment of patients with gout into studies and provide a structure that can inform clinical diagnosis. Under the new algorithm, the documented presence of monosodium urate (MSU) crystals in a symptomatic joint or tophus is a sufficient criterion for classifying gout. If these criteria are not met, a scoring system is applied that reflects characteristics of acute and chronic gout, including recent advances in imaging (see <a href="#T1">Table 1</a> as well as the New views: imaging section below). A score of at least 8 indicates gout<sup><a href="#ref-14">14</a></sup>. A convenient web-based gout classification calculator based on these criteria has been released by the University of Auckland in New Zealand (<a target=xrefwindow href="http://goutclassificationcalculator.auckland.ac.nz/" id=d25407e300>http://goutclassificationcalculator.auckland.ac.nz/</a>).</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Scoring system for classification of gout.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d25407e315 class=n-a></a><thead><a name=d25407e317 class=n-a></a><tr><a name=d25407e319 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d25407e321 class=n-a></a>Criteria</th><th align=left colspan=1 rowspan=1><a name=d25407e324 class=n-a></a>Category</th><th align=left colspan=1 rowspan=1><a name=d25407e327 class=n-a></a>Score</th></tr></thead><tbody><a name=d25407e332 class=n-a></a><tr><a name=d25407e334 class=n-a></a><td align=left colspan=1 rowspan=2 valign=top><a name=d25407e336 class=n-a></a>Pattern of joint/bursa involvement</td><td align=left colspan=1 rowspan=1><a name=d25407e339 class=n-a></a>Ankle or midfoot</td><td align=left colspan=1 rowspan=1><a name=d25407e342 class=n-a></a>1</td></tr><tr><a name=d25407e346 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d25407e348 class=n-a></a>First metatarsophalangeal<br class=br>joint</td><td align=left colspan=1 rowspan=1><a name=d25407e353 class=n-a></a>2</td></tr><tr><a name=d25407e357 class=n-a></a><td align=left colspan=1 rowspan=3 valign=top><a name=d25407e359 class=n-a></a>Episodic symptoms<br class=br>&nbsp;&nbsp;Erythema<br class=br>&nbsp;&nbsp;Pain or tenderness<br class=br>&nbsp;&nbsp;Functional disability</td><td align=left colspan=1 rowspan=1><a name=d25407e368 class=n-a></a>One symptom</td><td align=left colspan=1 rowspan=1><a name=d25407e371 class=n-a></a>1</td></tr><tr><a name=d25407e375 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d25407e377 class=n-a></a>Two symptoms</td><td align=left colspan=1 rowspan=1><a name=d25407e380 class=n-a></a>2</td></tr><tr><a name=d25407e384 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d25407e386 class=n-a></a>Three symptoms</td><td align=left colspan=1 rowspan=1><a name=d25407e389 class=n-a></a>3</td></tr><tr><a name=d25407e394 class=n-a></a><td align=left colspan=1 rowspan=2 valign=top><a name=d25407e396 class=n-a></a>Time course (at least two present):<br class=br>&nbsp;&nbsp;Time to maximal pain is less than<br class=br>24 hours<br class=br>&nbsp;&nbsp;Resolution of symptoms in not more<br class=br>than 14 days<br class=br>&nbsp;&nbsp;Complete resolution (to baseline)<br class=br>between episodes</td><td align=left colspan=1 rowspan=1><a name=d25407e412 class=n-a></a>One typical episode</td><td align=left colspan=1 rowspan=1><a name=d25407e415 class=n-a></a>1</td></tr><tr><a name=d25407e419 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d25407e421 class=n-a></a>Recurrent typical<br class=br>episodes</td><td align=left colspan=1 rowspan=1><a name=d25407e426 class=n-a></a>2</td></tr><tr><a name=d25407e430 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d25407e432 class=n-a></a>Clinical evidence of tophus</td><td align=left colspan=1 rowspan=1><a name=d25407e435 class=n-a></a>Present</td><td align=left colspan=1 rowspan=1><a name=d25407e438 class=n-a></a>4</td></tr><tr><a name=d25407e442 class=n-a></a><td align=left colspan=1 rowspan=4 valign=top><a name=d25407e444 class=n-a></a>Serum urate</td><td align=left colspan=1 rowspan=1><a name=d25407e447 class=n-a></a>&lt;4 mg/dL</td><td align=left colspan=1 rowspan=1><a name=d25407e450 class=n-a></a>4</td></tr><tr><a name=d25407e454 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d25407e456 class=n-a></a>68 mg/dL</td><td align=left colspan=1 rowspan=1><a name=d25407e459 class=n-a></a>2</td></tr><tr><a name=d25407e463 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d25407e465 class=n-a></a>8&lt;10 mg/dL</td><td align=left colspan=1 rowspan=1><a name=d25407e468 class=n-a></a>3</td></tr><tr><a name=d25407e473 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d25407e475 class=n-a></a>10 mg/dL</td><td align=left colspan=1 rowspan=1><a name=d25407e478 class=n-a></a>4</td></tr><tr><a name=d25407e482 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d25407e484 class=n-a></a>Synovial fluid analysis</td><td align=left colspan=1 rowspan=1><a name=d25407e487 class=n-a></a>MSU negative</td><td align=left colspan=1 rowspan=1><a name=d25407e490 class=n-a></a>2</td></tr><tr><a name=d25407e494 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d25407e496 class=n-a></a>Imaging evidence of serum urate<br class=br>deposition in symptomatic joint or bursa:<br class=br>&nbsp;&nbsp;Ultrasound: double-contour sign or<br class=br>&nbsp;&nbsp;Dual-energy computed tomography:<br class=br>serum urate deposition</td><td align=left colspan=1 rowspan=1><a name=d25407e507 class=n-a></a>Present (either modality)</td><td align=left colspan=1 rowspan=1><a name=d25407e510 class=n-a></a>4</td></tr><tr><a name=d25407e514 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d25407e516 class=n-a></a>Imaging evidence of gout-related<br class=br>damage:<br class=br>&nbsp;&nbsp;At least one erosion present in<br class=br>conventional radiography of hands<br class=br>or feet or both</td><td align=left colspan=1 rowspan=1><a name=d25407e527 class=n-a></a>Present</td><td align=left colspan=1 rowspan=1><a name=d25407e530 class=n-a></a>4</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d25407e538 class=n-a></a><p id=d25407e539> Adapted from the American College of Rheumatology/European League Against Rheumatism 2015 Gout Classification Criteria<sup><a href="#ref-14">14</a></sup>.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25407e552>New views: imaging</h2><p class="" id=d25407e555>Recent advances in technology, together with a better understanding of the pathophysiology of gout, have led to better non-invasive tools facilitating the diagnosis and management of gout. The accelerating use of ultrasound and dual-energy computed tomography (DECT) is contributing to improvements in gout diagnosis, study, and management.</p><p class="" id=d25407e558>The appropriate combination of symptoms on historytogether with ultrasound findings of tophi, effusions with snowstorm appearance, and the pathognomonic double contour sign (deposition on the surface of articular cartilage)may approach the sensitivity and specificity of joint aspiration for crystal examination and potentially preclude invasive intervention in at least some patients with gout (<a href="#f1">Figure 1a</a>)<sup><a href="#ref-15">15</a><a href="#ref-17">17</a></sup>. Although its use is currently limited by cost and availability, DECT can provide an accurate quantification of MSU crystal aggregates in both joints and soft tissues and permits the identification of deposits not appreciated by clinical examination. In the future, DECT may permit both recognition of occult deposits (total body burden) and monitoring of therapy to establish endpoints based on urate burden resolution (<a href="#f1">Figure 1b</a>)<sup><a href="#ref-18">18</a></sup>. The most up-to-date DECT technology (dual-source CT) results in radiation exposure that is no greater than that of conventional CT<sup><a href="#ref-19">19</a></sup>, with a single study of one extremity providing radiation exposure approximately equivalent to 4 months of natural background radiation. Nonetheless, this level of radiation exposure may limit the use of DECT on a recurring basis, as would be necessary when monitoring therapy. Regular CT, nuclear medicine, and magnetic resonance imaging have demonstrated utility in assisting the diagnosis of gout, especially in atypical presentations or cases managed by inexperienced providers.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/10126/bad6dc1a-8c49-44e5-8879-9b6673996c1d_figure1.gif"><img alt="bad6dc1a-8c49-44e5-8879-9b6673996c1d_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/10126/bad6dc1a-8c49-44e5-8879-9b6673996c1d_figure1.gif"></a><div class=caption><h3>Figure 1. New imaging modalities for demonstrating serum urate deposition.</h3><p id=d25407e592>(<b>A</b>) Musculoskeletal ultrasound of a first metatarsal phalangeal joint (plantar longitudinal view) demonstrating a classic double contour sign (arrows), indicating the deposition of monosodium urate (MSU) crystals on the cartilage surface of the metatarsal head. (<b>B</b>) Dual-energy computed tomography of a foot. Green areas indicate MSU deposition, and arrows indicate the presence of MSU deposition at the first distal interphalangeal joint, at the carpal metacarpal joint, and along the Achilles tendon.</p></div></div><p class="" id=d25407e605>Use of these imaging modalities has led to a shift in the paradigm about how gout begins. Formerly, most practitioners assumed that the first acute attack of gout was preceded by hyperuricemia and would be followed later by tissue MSU crystal deposition. However, both ultrasound and DECT have demonstrated the presence of MSU deposition in patients with hyperuricemia, even before the first gout attack<sup><a href="#ref-18">18</a></sup>. These observations suggest that by the time a patient has a first gout attack, he or she has already deposited MSU crystals in joints and tissues that will need to be depleted in the process of chronic gout management<sup><a href="#ref-20">20</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25407e619>New drugs</h2><p class="" id=d25407e622>The field of gout therapeutics came to a virtual standstill in the latter half of the 20th century, during which no new drugs were approved for clinical use. In contrast, the early 21st century has witnessed a renaissance of gout therapy, beginning with the development of the xanthine oxidase inhibitor (XOI) febuxostat. It is a mark of the advancement of gout care in the last decade that, in this review, we will consider febuxostat to be an old advance and not discuss it further.</p><div class=section><a name=d25407e625 class=n-a></a><h3 class=section-title>New anti-inflammatory strategies</h3><p class="" id=d25407e630>Interleukin-1 beta (IL-1) is synthesized on ribosomes as pro-IL-1, an inactive molecule whose expression can be upregulated by multiple inflammatory stimuli. When converted to its active state by the NOD-like receptor protein 3 (NLRP3) inflammasome, IL-1 orchestrates much of the crystal-induced inflammatory response seen in acute gout<sup><a href="#ref-21">21</a><a href="#ref-23">23</a></sup>. The NLRP3 inflammasome is a multi-molecular complex composed of NLRP3, pro-caspase-1, and the adapter ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain). Pathogen-derived or endogenous danger signals activate the NLRP3 inflammasome, leading to caspase-1 activation and activation and secretion of IL-1<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a></sup>. The essential role of the NLRP3 inflammasome in acute gout attacks was recognized less than a decade ago, and the mechanisms through which MSU crystals activate the NLRP3 inflammasome are still under study (<a href="#f2">Figure 2</a>). Appreciation of the centrality of IL-1 to gouty inflammation has led to the off-label use of anti-IL-1 therapies for patients who do not adequately respond to or cannot tolerate traditional gout medications.</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/10126/bad6dc1a-8c49-44e5-8879-9b6673996c1d_figure2.gif"><img alt="bad6dc1a-8c49-44e5-8879-9b6673996c1d_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/10126/bad6dc1a-8c49-44e5-8879-9b6673996c1d_figure2.gif"></a><div class=caption><h3>Figure 2. Activation of the NLRP3 inflammasome and the production IL-1.</h3><p id=d25407e660>(<b>1</b>) Monosodium urate (MSU) crystal phagocytosis stimulates the NADPH (nicotinamide adenine dinucleotide phosphate) oxidase to generate reactive oxygen species that in turn can activate the NLRP3 (NOD-like receptor protein 3) inflammasome. (<b>2</b>) MSU crystals may also stimulate the secretion of ATP, which can engage and activate the purinergic receptor P2X7, resulting in recruitment of pannexin-1 channels. The resultant rapid efflux of potassium, and the lowering of intracellular potassium, can also trigger inflammasome activation. (<b>3</b>) Concurrently, MSU crystal interactions with Toll-like receptors (TLRs) on the cell surface stimulate the production of pro-IL-1 via MyD88- and NF-B-dependent pro-IL-1 gene transcription. (<b>4</b>) Once stimulated, the NLRP3 inflammasomes enzymatic effector caspase-1 cleaves the pro-IL-1 to biologically active IL-1. IL-1 is then secreted from the cell into the extra-cellular fluid of the site of inflammation. ASC, apoptosis-associated speck-like protein containing a caspase recruitment domain; IL-1, interleukin-1 beta; NF-B, nuclear factor-kappa B; NLRP3, NOD-like receptor protein 3; ROS, reactive oxygen species; TLR, Toll-like receptor.</p></div></div><p class="" id=d25407e679><b><i>Canakinumab.</i></b> Canakinumab, a monoclonal antibody, neutralizes IL-1 to suppress inflammation. Canakinumab is US Food and Drug Administration (FDA)-approved for cryopyrin-associated periodic fever syndromes, Muckle-Wells syndrome, familial cold auto-inflammatory syndrome, and systemic idiopathic juvenile arthritis. Phase 3 trials of canakinumab by Schlesinger <i>et al</i>. demonstrated its efficacy in acute gout and for prophylaxis during sUA-lowering therapy (ULT)<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>. The FDA declined to approve canakinumab for acute gout therapy, citing concerns about the use of a long-acting immunosuppressant for an ostensibly short-term condition. In contrast, the European Medicines Agency approved canakinumab for the same indication.</p><p class="" id=d25407e695><b><i>Anakinra.</i></b> Anakinra is a recombinant human IL-1 receptor antagonist that is FDA-approved for rheumatoid arthritis and neonatal-onset multi-system inflammatory disease. To date, randomized controlled trials assessing anakinras efficacy in the management of gout are lacking<sup><a href="#ref-28">28</a></sup>, but case series and uncontrolled trials support its efficacy<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. In practice, anakinra has been the preferred off-label anti-IL-1 strategy among experienced goutologists, based on its relatively short half-life and lower cost compared with canakinumab.</p></div><div class=section><a name=d25407e713 class=n-a></a><h3 class=section-title>New approaches to serum urate lowering</h3><p class="" id=d25407e718>Because hyperuricemia is the underlying condition promoting gout, long-term treatment of gout almost always involves the therapeutic lowering of serum and tissue sUA levels. Several new ULTs are finding their way into the pharmacopaeia.</p><p class="" id=d25407e721><b><i>Pegloticase.</i></b> Pegloticase is a recombinant, pegylated uricase that degrades uric acid<sup><a href="#ref-31">31</a></sup>. Approved by the FDA in 2010, pegloticase is indicated for the treatment of hyperuricaemia in adults with chronic or tophaceous gout refractory to conventional ULT. Pegloticase is administered intravenously every 2 weeks. Studies confirm the ability of pegloticase to rapidly and dramatically lower sUA and to promote the often-dramatic resolution of tophi<sup><a href="#ref-32">32</a></sup>.</p><p class="" id=d25407e735>Several safety considerations arose during randomized controlled trials of pegloticase. As for all ULTs, pegloticase administration transiently raises the risk of gout flares. Therefore, gout flare prophylaxis is recommended for at least the first 6 months of pegloticase therapy. Pegloticase should be avoided in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, as its action generates oxidants that may increase the risk of hemolysis and methemoglobinemia in such individuals. Because of infusion-associated volume loads, pegloticase should also be avoided in patients with uncompensated heart failure<sup><a href="#ref-33">33</a></sup>.</p><p class="" id=d25407e742>The biggest safety concern, and the most recurring cause of discontinuation in the trials, is the risk of infusion reactions. These reactions are generally mild but may be severe and necessitate pre-medication with glucocorticoids. Because both loss of drug efficacy and most infusion reactions reflect the development of anti-pegloticase antibodies (ironically, mainly directed at the polyethylene glycol portion, the very modification added to prevent such reactions<sup><a href="#ref-34">34</a></sup>), the risk of reactions can be greatly reduced by discontinuing pegloticase in patients whose sUA exceeds 6.0 mg/dL prior to infusion on two consecutive occasions<sup><a href="#ref-35">35</a></sup>. Oral ULTs are contraindicated during pegloticase use, to prevent masking any loss of pegloticase efficacy<sup><a href="#ref-35">35</a></sup>. Though highly effective, such a safety strategy does not solve the overall treatment problem for patients with severe gout who need but cannot tolerate the agent; therefore, investigations to try to identify strategies to reduce the risk of pegloticase intolerance are ongoing<sup><a href="#ref-36">36</a></sup>.</p><p class="" id=d25407e762><b><i>Lesinurad.</i></b> Lesinurad is a selective, highly potent uric acid reabsorption inhibitor. Lesinurad reduces sUA by inhibiting both the sUA-anion exchanger transporter 1 (URAT1) and the organic anion transporter 4 (OAT4), which are involved in the reabsorption of sUA across the renal proximal tubule<sup><a href="#ref-37">37</a></sup>. In contrast to the older uricosuric probenecid, lesinurad is more potent and remains effective even in moderate renal insufficiency. In 2015, lesinurad gained FDA approval as a second-line treatment for gout patients who have failed to meet target sUA despite treatment with a traditional XOI ULT (that is, allopurinol or febuxostat).</p><p class="" id=d25407e772>The Combination Study of Lesinurad in Allopurinol Standard of Care Inadequate Responders (CLEAR 1 and CLEAR 2) assessed the efficacy of lesinurad (200 or 400 mg daily) as a ULT. The addition of lesinurad to standard allopurinol care increased the proportion of patients successfully meeting sUA targets by as much as 2.5-fold<sup><a href="#ref-38">38</a></sup>. Similarly, the CRYSTAL study compared combination therapy with lesinurad and febuxostat with febuxostat monotherapy in the treatment of hyperuricemia and resolution of tophi. Combination therapy increased the number of patients achieving target sUA below 5 mg/dL compared with febuxostat alone and resulted in improved tophus resolution<sup><a href="#ref-39">39</a></sup>. In both studies, the 400 mg dose of lesinurad was associated with an increased frequency of serum creatinine elevations compared with the 200 mg dose or with XOI alone. Another study, the LIGHT (lesinurad monotherapy in gout patients intolerant to XOIs) study, also demonstrated a potential for creatinine increases when using the 400 mg dose as monotherapy<sup><a href="#ref-40">40</a></sup>. For this reason, lesinurad is approved only at the 200 mg dose and only in conjunction with an XOI. Baseline assessment and periodic testing of renal function are required, particularly for patients with creatinine clearance below 60 mL/min.</p><p class="" id=d25407e787><b><i>Arhalofenate.</i></b> Arhalofenate is a pipeline drug with a dual mechanism of action. Patients initiating ULT are routinely prescribed concurrent anti-inflammatory prophylaxis to reduce the risk of gout attacks precipitated by the sUA-lowering process itself. Historically, all gout medications have been either anti-inflammatory or sUA-lowering. In contrast, arhalofenate, a peroxisome proliferator-activated receptor-gamma (PPAR-) partial agonist, demonstrates dual ULT and anti-inflammatory effects. Specifically, arhalofenate inhibits expression of IL-1 while inhibiting renal reabsorption of uric acid at the URAT1, OAT4, and OAT10 transporters<sup><a href="#ref-41">41</a></sup>.</p><p class="" id=d25407e797>A randomized controlled trial assessed the effectiveness of arhalofenate compared to allopurinol and placebo. Though demonstrating a greater capacity for sUA lowering than placebo, it did not show superiority over allopurinol. Similarly, arhalofenate did not appear to be as effective as traditionally used anti-inflammatories<sup><a href="#ref-42">42</a></sup>. Nonetheless, the possibility that the dual action of arhalofenate permits single-drug regimens for at least some patients with gout could improve compliance for this disease in which patientsand their physicianshave been notoriously non-compliant with treatment.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25407e809>New treatment guidelines</h2><p class="" id=d25407e812>In 2012, the ACR published its first gout treatment guidelines. These guidelines reasserted that chronic gout needs chronic treatment and integrated the issues of anti-inflammation, ULT, and lifestyle risk management. With an emphasis on early management of gout, the guidelines promote evidence-based best practice, improve quality of therapy, and enhance patient safety.</p><p class="" id=d25407e815>Recommendations were reached after a formal review procedure by a multi-center, international team of gout physician experts. Innovations include guidance on the proper time to initiate ULT (in the setting of two attacks within the same year or after one attack in patients with stage 2 or greater renal disease, tophi, or kidney stones), an emphasis on treat-to-target strategies (an initial target of less than 6.0 mg/dL and lower as needed to control attacks or resolve tophi or both), the use of uricosuric agents and pegloticase as second- and third-line ULTs, and a sidelong endorsement of off-label anti-IL-1 biologics when conventional anti-inflammatory strategies fail<sup><a href="#ref-28">28</a>,<a href="#ref-43">43</a></sup>.</p><p class="" id=d25407e825>With the introduction of novel gout medications and new information regarding traditional gout therapy, the EULAR has recently published its own gout management guidelines. In contrast to the ACR, the EULAR recommends consideration of ULT initiation in every patient with a definite diagnosis of gout at first presentation. This recommendation advances the initiation of ULT to an earlier point in the disease, reflecting the awareness that by the time a patients first attack occurs he or she should already be considered to have a chronic disease, potentially with occult MSU crystal deposition, and that clearance of MSU crystals may be more difficult once a larger crystal burden has become established<sup><a href="#ref-44">44</a></sup>. Indeed, recent imaging studies suggest that MSU deposition can be identified in a significant percentage of patients with hyperuricemia, even before their first gout attack<sup><a href="#ref-45">45</a></sup>.</p><p class="" id=d25407e836>While the evidence base regarding early ULT intervention continues to evolve, recent studies suggest that delayed initiation of ULT may increase the cardiovascular and renal risk associated with greater exposure to hyperuricemic states (see New Risksand Benefits?of Hyperuricemia, below)<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup> and that prompt and comprehensive ULT may reduce the risk of associated cardiovascular and renal morbidity<sup><a href="#ref-48">48</a></sup>. However, current studies are either retrospective or too small to be considered pivotal, and the notion of early ULT intervention remains somewhat controversial, particularly outside of the rheumatology community. The EULAR recommendation to consider initiating ULT even after a single gout attack is based primarily on expert opinion, and controversy recently erupted with the release of American College of Physicians gout treatment guidelines, which fail to enthusiastically recommend chronic ULT use or treat-to-serum urate target strategies in patients with chronic gout<sup><a href="#ref-49">49</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25407e857>New genetics for screening</h2><p class="" id=d25407e860>The human leukocyte antigen B (HLA-B), a cell surface protein involved in the recognition and presentation of foreign antigens, is critical to immune defense. One variant of this gene, the HLA-B*58:01 allele, has been strongly linked to increased (&gt;100-fold) risk for severe cutaneous and systemic adverse reactions upon treatment with allopurinol. HLA-B*58:01 has been most commonly associated with Asian cohorts. Among Han Chinese<sup><a href="#ref-50">50</a></sup> and Thai<sup><a href="#ref-51">51</a></sup> individuals, the allele has been found in 100% of patients with allopurinol hypersensitivity reactions. In Korean<sup><a href="#ref-52">52</a></sup> patients, the allele was also present in 80% of allopurinol hypersensitivity reactions, a number far greater than the 12% seen in healthy controls.</p><p class="" id=d25407e875>Therefore, the current ACR gout management guidelines recommend testing all patients of Han Chinese and Thai ancestry and all patients of Korean descent with at least stage 3 renal failure<sup><a href="#ref-43">43</a></sup>. The Clinical Pharmacogenomics Implementation Consortium recommends that allopurinol not be prescribed to patients positive for HLA-B*58:01<sup><a href="#ref-53">53</a></sup>. Pharmacoeconomic analyses of HLA-B*58:01 genotyping in high-risk patients suggest that such a testing strategy is cost-effective<sup><a href="#ref-54">54</a></sup>.</p><p class="" id=d25407e890>Very recent studies by Lu <i>et al</i>. and others have addressed the fact that, like some Asian populations, African-Americans may have a higher prevalence of HLA-B*58:01. In a recent multi-center study, the risks of allopurinol hypersensitivity reactions in the Asian and African-American subpopulations were 12 and 5 times greater, respectively, compared with Caucasians. These figures were concordant with the observed incidence ratios of the HLA-B*58:01 allele in the particular patient populations (7.4% in Asian cohorts, 4% in African-American cohorts, and 1% in Caucasian cohorts)<sup><a href="#ref-55">55</a></sup>. The large number of African-Americans potentially genetically predisposed to allopurinol hypersensitivity associated with the HLA-B*58:01 gene raises the question of whether widespread testing of this population is warranted.</p><p class="" id=d25407e900>Recent data have alluded to a potential risk reduction in allopurinol hypersensitivity syndrome with graded dose introduction of ULT<sup><a href="#ref-56">56</a></sup>. As a result, ACR treatment guidelines recommend starting all patients on allopurinol at a low dose and titrating up gradually until a target sUA is achieved<sup><a href="#ref-43">43</a></sup>. Whether the degree of risk reduction obtained using this strategy is sufficient to allow practitioners to eschew universal HLA-B*5801 testing in populations at high risk for allopurinol hypersensitivity has not been directly studied.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25407e914>New risksand benefits?of hyperuricemia</h2><p class="" id=d25407e917>There is growing recognition within the gout community of a potentially causative relationship between hyperuricemia and cardiovascular disease, and multiple large population studies have examined this association. Despite differences in study populations and varying conclusions, almost all of the studies confirmed that hyperuricemia is an independent risk factor for adverse cardiovascular outcomes<sup><a href="#ref-57">57</a></sup>. A similar potential adverse effect of hyperuricemia has been examined rigorously in connection with chronic kidney disease<sup><a href="#ref-58">58</a></sup>. Studies suggest that high sUA concentrations impact the level of kidney damage and also are associated with a larger risk of secondary hypertension<sup><a href="#ref-58">58</a></sup>. A number of small interventional trials, and large population-based studies in patients with either hyperuricemia or gout, suggest that treatment with ULTs may reduce the risk of these adverse outcomes<sup><a href="#ref-59">59</a><a href="#ref-61">61</a></sup>. Pivotal clinical trials will be needed to determine whether ULT treatment is warranted to lower co-morbid risk in hyperuricemic individuals either with or without gout.</p><p class="" id=d25407e939>Whereas rheumatologists and their patients view high sUA levels and the acute attacks they bring as inherently undesirable, some neurologists believe that the anti-oxidant properties of sUA may have neuroprotective benefits against Alzheimers and possibly other neurodegenerative diseases. Within the bloodstreamand presumably within the central nervous systemsUA provides the greatest extra-cellular contribution to anti-oxidation.</p><p class="" id=d25407e942>Using data obtained from the Health Improvement Network, an electronic medical record database representative of the population of the United Kingdom, Lu <i>et al</i>. studied the relationship between gout/hyperuricemia and Alzheimers disease. In their age-matched, sex-matched, body mass index-matched, and entry time-matched cohort study, gout was inversely associated with the risk of developing Alzheimers disease. Univariate and multi-variate hazard ratios for Alzheimers disease diagnosed in patients with gout were 0.71 (95% confidence interval [CI] 0.62 to 0.80) and 0.76 (95% CI 0.66 to 0.87), respectively<sup><a href="#ref-62">62</a></sup>. Similarly, sUA levels in patients with multiple sclerosis are significantly lower than those of healthy controls, and few if any cases of co-morbid gout and multiple sclerosis have been reported<sup><a href="#ref-63">63</a>,<a href="#ref-64">64</a></sup>. Other studies have tentatively identified similar relationships between gout and sUA and both Parkinsons<sup><a href="#ref-65">65</a></sup> and Huntingtons<sup><a href="#ref-66">66</a></sup> diseases. However, not all studies have recognized this possible beneficial effect<sup><a href="#ref-67">67</a></sup>.</p><p class="" id=d25407e972>Since the putative neuroprotective relationship between uric acid and central nervous system disorders is a relatively new concept, there is currently no guidance as to what specific level of sUA, if any, might represent an appropriate balance between neuroprotective benefit and gout/gout co-morbidity risk. Therefore, further studies are required to confirm that higher sUA levels actually provide a neurologic benefit and to re-evaluate what constitutes a healthy sUA level in both gout and non-gout patients. Importantly, there are currently no data to suggest that urate lowering in patients with hyperuricemia increases the likelihood of either developing a neurodegenerative disease or worsening such a process if already present.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25407e978>Conclusions</h2><p class="" id=d25407e981>With recent advances in our understanding of the pathophysiology of hyperuricemia and crystal inflammation, gout has once again come to the fore as a disease bearing serious implications and requiring intricate therapy. New appreciation of the centrality of IL-1 and the inflammasome and greater insight into the transporters crucial to renal sUA handling have paved the way for the introduction of novel gout therapeutics with diverse modes of action. Similarly, with growing understanding of the genetics behind gout and the multiple functions of sUA, recommendations for the management of gout are undergoing evolution and refinement.</p><p class="" id=d25407e984>With improvements in both patient and provider comprehension of gout as both an acutely debilitating and chronic disease, developments in gout pharmaceutics, and ongoing research into the disease biology, the rheumatologic community continues to make significant headway in producing adequate control of sUA and prevention of acute gout flares.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d25407e1 class=n-a></a><h2 class=main-title id=d25618>Competing interests</h2><p class=metadata-entry><a name=d25407e113 class=n-a></a><p id=d25407e114> Talia F. Igel declares that she has no competing interests. Svetlana Krasnokutsky has served as a consultant for Crealta, Horizon and Ironwood. Michael H. Pillinger serves or has served as a consultant for AstraZeneca, Crealta, Horizon, Ironwood and Sobi and has been an investigative site for a sponsored trial by Takeda.</p></p></div><div class=back-section><a name=d25407e1 class=n-a></a><h2 class=main-title id=d25620>Grant information</h2><p>TFI was supported in part by a travel scholarship from Monash University. SK was supported in part by an Investigator Award from the Rheumatology Research Foundation and by a New York State Empire Clinical Research Investigator Program award. MHP receives salary support from NYU CTSA grant 1UL1TR001445 from the National Center for the Advancement of Translational Science, National Institutes of Health.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d25407e991 class=n-a></a><h2 class=main-title id=d25407e993>Acknowledgments</h2><p class="" id=d25407e996>The authors thank Adey Berhanu, Cesar Fors, and Jonathan Samuels for providing the ultrasound image of the double contour sign and Soterios Gyftopoulos for providing the DECT image. We thank N. Lawrence Edwards and Richard O. Day for helpful comments.</p></div><div class=back-section><a name=d25407e1000 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d25855>References</h2><div class="section ref-list"><a name=d25407e1000 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725620930"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1007 class=n-a></a>Kuo CF, Grainge MJ, Zhang W, <i> et al.</i>: Global epidemiology of gout: prevalence, incidence and risk factors. <i>Nat Rev Rheumatol.</i> 2015; <b>11</b>(11): 64962. <a target=xrefwindow id=d25407e1018 href="http://www.ncbi.nlm.nih.gov/pubmed/26150127">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1021 href="http://dx.doi.org/10.1038/nrrheum.2015.91">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725620930">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d25407e1034 class=n-a></a>Edwards NL: Quality of care in patients with gout: why is management suboptimal and what can be done about it? <i>Curr Rheumatol Rep.</i> 2011; <b>13</b>(2): 1549. <a target=xrefwindow id=d25407e1042 href="http://www.ncbi.nlm.nih.gov/pubmed/21161617">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1045 href="http://dx.doi.org/10.1007/s11926-010-0154-6">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d25407e1054 class=n-a></a>Terkeltaub R, Bushinsky DA, Becker MA: Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. <i>Arthritis Res Ther.</i> 2006; <b>8</b>(Suppl 1): S4. <a target=xrefwindow id=d25407e1062 href="http://www.ncbi.nlm.nih.gov/pubmed/16820043">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1065 href="http://dx.doi.org/10.1186/ar1909">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1068 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3226109">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d25407e1077 class=n-a></a>Bobulescu IA, Moe OW: Renal transport of uric acid: evolving concepts and uncertainties. <i>Adv Chronic Kidney Dis.</i> 2012; <b>19</b>(6): 35871. <a target=xrefwindow id=d25407e1085 href="http://www.ncbi.nlm.nih.gov/pubmed/23089270">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1088 href="http://dx.doi.org/10.1053/j.ackd.2012.07.009">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1091 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3619397">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d25407e1100 class=n-a></a>Pascual E, Perdiguero M: Gout, diuretics and the kidney. <i>Ann Rheum Dis.</i> 2006; <b>65</b>(8): 9812. <a target=xrefwindow id=d25407e1108 href="http://www.ncbi.nlm.nih.gov/pubmed/16837492">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1111 href="http://dx.doi.org/10.1136/ard.2005.049023">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1114 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1798242">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727303292"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1124 class=n-a></a>Hyndman D, Liu S, Miner JN: Urate Handling in the Human Body. <i>Curr Rheumatol Rep.</i> 2016; <b>18</b>(6): 34. <a target=xrefwindow id=d25407e1132 href="http://www.ncbi.nlm.nih.gov/pubmed/27105641">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1135 href="http://dx.doi.org/10.1007/s11926-016-0587-7">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1138 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4841844">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727303292">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726439256"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1151 class=n-a></a>Liu S, Perez-Ruiz F, Miner JN: Patients with gout differ from healthy subjects in renal response to changes in serum uric acid. <i>Joint Bone Spine.</i> 2016; pii: S1297-319X(16)30071-9. <a target=xrefwindow id=d25407e1156 href="http://www.ncbi.nlm.nih.gov/pubmed/27324603">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1159 href="http://dx.doi.org/10.1016/j.jbspin.2016.04.007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726439256">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13353968"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1172 class=n-a></a>Ichida K, Hosoyamada M, Hisatome I, <i> et al.</i>: Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. <i>J Am Soc Nephrol.</i> 2004; <b>15</b>(1): 16473. <a target=xrefwindow id=d25407e1183 href="http://www.ncbi.nlm.nih.gov/pubmed/14694169">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1186 href="http://dx.doi.org/10.1097/01.ASN.0000105320.04395.D0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13353968">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d25407e1199 class=n-a></a>Tin A, Woodward OM, Kao WH, <i> et al.</i>: Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. <i>Hum Mol Genet.</i> 2011; <b>20</b>(20): 405668. <a target=xrefwindow id=d25407e1210 href="http://www.ncbi.nlm.nih.gov/pubmed/21768215">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1213 href="http://dx.doi.org/10.1093/hmg/ddr307">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1217 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3177647">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13353964"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1226 class=n-a></a>Kolz M, Johnson T, Sanna S, <i> et al.</i>: Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. <i>PLoS Genet.</i> 2009; <b>5</b>(6): e1000504. <a target=xrefwindow id=d25407e1237 href="http://www.ncbi.nlm.nih.gov/pubmed/19503597">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1240 href="http://dx.doi.org/10.1371/journal.pgen.1000504">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1244 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2683940">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13353964">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725340982"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1257 class=n-a></a>Matsuo H, Yamamoto K, Nakaoka H, <i> et al.</i>: Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes. <i>Ann Rheum Dis.</i> 2016; <b>75</b>(4): 6529. <a target=xrefwindow id=d25407e1268 href="http://www.ncbi.nlm.nih.gov/pubmed/25646370">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1271 href="http://dx.doi.org/10.1136/annrheumdis-2014-206191">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1275 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4819613">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725340982">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725440855"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1289 class=n-a></a>Merriman TR: An update on the genetic architecture of hyperuricemia and gout. <i>Arthritis Res Ther.</i> 2015; <b>17</b>(1): 98. <a target=xrefwindow id=d25407e1297 href="http://www.ncbi.nlm.nih.gov/pubmed/25889045">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1300 href="http://dx.doi.org/10.1186/s13075-015-0609-2">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1303 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4392805">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725440855">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717968843"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1316 class=n-a></a>Kttgen A, Albrecht E, Teumer A, <i> et al.</i>: Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. <i>Nat Genet.</i> 2013; <b>45</b>(2): 14554. <a target=xrefwindow id=d25407e1327 href="http://www.ncbi.nlm.nih.gov/pubmed/23263486">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1330 href="http://dx.doi.org/10.1038/ng.2500">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1334 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3663712">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717968843">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725777945"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1347 class=n-a></a>Neogi T, Jansen TL, Dalbeth N, <i> et al.</i>: 2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. <i>Arthritis Rheumatol.</i> 2015; <b>67</b>(10): 255768. <a target=xrefwindow id=d25407e1358 href="http://www.ncbi.nlm.nih.gov/pubmed/26352873">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1361 href="http://dx.doi.org/10.1002/art.39254">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1365 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4566153">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725777945">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d25407e1378 class=n-a></a>Thiele RG: Role of ultrasound and other advanced imaging in the diagnosis and management of gout. <i>Curr Rheumatol Rep.</i> 2011; <b>13</b>(2): 14653. <a target=xrefwindow id=d25407e1386 href="http://www.ncbi.nlm.nih.gov/pubmed/21210257">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1389 href="http://dx.doi.org/10.1007/s11926-010-0156-4">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d25407e1398 class=n-a></a>Ogdie A, Taylor WJ, Neogi T, <i> et al.</i>: Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard. <i>Arthritis Rheumatol.</i> 2017; <b>69</b>(2): 429438. <a target=xrefwindow id=d25407e1409 href="http://www.ncbi.nlm.nih.gov/pubmed/27748084">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1412 href="http://dx.doi.org/10.1002/art.39959">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1416 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5278908">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d25407e1425 class=n-a></a>Kissin EY, Pillinger MH: Editorial: The Sound and the Fury: Musculoskeletal Ultrasound in the Diagnosis of Gout. <i>Arthritis Rheumatol.</i> 2017; <b>69</b>(2): 249252. <a target=xrefwindow id=d25407e1433 href="http://www.ncbi.nlm.nih.gov/pubmed/27748075">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1436 href="http://dx.doi.org/10.1002/art.39958">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d25407e1446 class=n-a></a>Girish G, Melville DM, Kaeley GS, <i> et al.</i>: Imaging appearances in gout. <i>Arthritis.</i> 2013; <b>2013</b>: 673401. <a target=xrefwindow id=d25407e1457 href="http://www.ncbi.nlm.nih.gov/pubmed/23585966">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1460 href="http://dx.doi.org/10.1155/2013/673401">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1464 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3621383">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d25407e1473 class=n-a></a>Henzler T, Fink C, Schoenberg SO, <i> et al.</i>: Dual-energy CT: radiation dose aspects. <i>AJR Am J Roentgenol.</i> 2012; <b>199</b>(5 Suppl): S1625. <a target=xrefwindow id=d25407e1484 href="http://www.ncbi.nlm.nih.gov/pubmed/23097163">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1487 href="http://dx.doi.org/10.2214/AJR.12.9210">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d25407e1496 class=n-a></a>Perez-Ruiz F, Dalbeth N, Bardin T: A review of uric acid, crystal deposition disease, and gout. <i>Adv Ther.</i> 2015; <b>32</b>(1): 3141. <a target=xrefwindow id=d25407e1504 href="http://www.ncbi.nlm.nih.gov/pubmed/25533440">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1507 href="http://dx.doi.org/10.1007/s12325-014-0175-z">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1510 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4311063">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1008963"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1519 class=n-a></a>Martinon F, Burns K, Tschopp J: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. <i>Mol Cell.</i> 2002; <b>10</b>(2): 41726. <a target=xrefwindow id=d25407e1527 href="http://www.ncbi.nlm.nih.gov/pubmed/12191486">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1530 href="http://dx.doi.org/10.1016/S1097-2765(02)00599-3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1008963">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8153"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1543 class=n-a></a>Martinon F, Ptrilli V, Mayor A, <i> et al.</i>: Gout-associated uric acid crystals activate the NALP3 inflammasome. <i>Nature.</i> 2006; <b>440</b>(7081): 23741. <a target=xrefwindow id=d25407e1554 href="http://www.ncbi.nlm.nih.gov/pubmed/16407889">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1557 href="http://dx.doi.org/10.1038/nature04516">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8153">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d25407e1570 class=n-a></a>Martinon F: Signaling by ROS drives inflammasome activation. <i>Eur J Immunol.</i> 2010; <b>40</b>(3): 6169. <a target=xrefwindow id=d25407e1578 href="http://www.ncbi.nlm.nih.gov/pubmed/20201014">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1581 href="http://dx.doi.org/10.1002/eji.200940168">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d25407e1591 class=n-a></a>Busso N, So A: Mechanisms of inflammation in gout. <i>Arthritis Res Ther.</i> 2010; <b>12</b>(2): 206. <a target=xrefwindow id=d25407e1599 href="http://www.ncbi.nlm.nih.gov/pubmed/20441605">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1602 href="http://dx.doi.org/10.1186/ar2952">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1605 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2888190">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d25407e1614 class=n-a></a>Kingsbury SR, Conaghan PG, McDermott MF: The role of the NLRP3 inflammasome in gout. <i>J Inflamm Res.</i> 2011; <b>4</b>: 3949. <a target=xrefwindow id=d25407e1622 href="http://www.ncbi.nlm.nih.gov/pubmed/22096368">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1625 href="http://dx.doi.org/10.2147/JIR.S11330">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1628 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3218743">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d25407e1637 class=n-a></a>Schlesinger N, Mysler E, Lin HY, <i> et al.</i>: Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. <i>Ann Rheum Dis.</i> 2011; <b>70</b>(71): 126471. <a target=xrefwindow id=d25407e1648 href="http://www.ncbi.nlm.nih.gov/pubmed/21540198">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1651 href="http://dx.doi.org/10.1136/ard.2010.144063">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1655 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3103669">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/716597950"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1664 class=n-a></a>Schlesinger N, Alten RE, Bardin T, <i> et al.</i>: Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. <i>Ann Rheum Dis.</i> 2012; <b>71</b>(11): 183948. <a target=xrefwindow id=d25407e1675 href="http://www.ncbi.nlm.nih.gov/pubmed/22586173">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1678 href="http://dx.doi.org/10.1136/annrheumdis-2011-200908">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/716597950">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d25407e1691 class=n-a></a>Khanna D, Khanna PP, Fitzgerald JD, <i> et al.</i>: 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. <i>Arthritis Care Res (Hoboken).</i> 2012; <b>64</b>(10): 144761. <a target=xrefwindow id=d25407e1702 href="http://www.ncbi.nlm.nih.gov/pubmed/23024029">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1705 href="http://dx.doi.org/10.1002/acr.21773">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1709 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3662546">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d25407e1718 class=n-a></a>So A, De Smedt T, Revaz S, <i> et al.</i>: A pilot study of IL-1 inhibition by anakinra in acute gout. <i>Arthritis Res Ther.</i> 2007; <b>9</b>(2): R28. <a target=xrefwindow id=d25407e1729 href="http://www.ncbi.nlm.nih.gov/pubmed/17352828">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1732 href="http://dx.doi.org/10.1186/ar2143">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1736 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1906806">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d25407e1746 class=n-a></a>Ottaviani S, Molt A, Ea HK, <i> et al.</i>: Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases. <i>Arthritis Res Ther.</i> 2013; <b>15</b>(5): R123. <a target=xrefwindow id=d25407e1757 href="http://www.ncbi.nlm.nih.gov/pubmed/24432362">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1760 href="http://dx.doi.org/10.1186/ar4303">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1764 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3978950">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d25407e1773 class=n-a></a>Shannon JA, Cole SW: Pegloticase: a novel agent for treatment-refractory gout. <i>Ann Pharmacother.</i> 2012; <b>46</b>(3): 36876. <a target=xrefwindow id=d25407e1781 href="http://www.ncbi.nlm.nih.gov/pubmed/22395256">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1784 href="http://dx.doi.org/10.1345/aph.1Q593">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d25407e1793 class=n-a></a>Baraf HS, Becker MA, Gutierrez-Urena SR, <i> et al.</i>: Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy. <i>Arthritis Res Ther.</i> 2013; <b>15</b>(5): R137. <a target=xrefwindow id=d25407e1804 href="http://www.ncbi.nlm.nih.gov/pubmed/24286509">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1807 href="http://dx.doi.org/10.1186/ar4318">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1811 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3979037">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727303300"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1820 class=n-a></a>Gentry WM, Dotson MP, Williams BS, <i> et al.</i>: Investigation of pegloticase-associated adverse events from a nationwide reporting system database. <i>Am J Health Syst Pharm.</i> 2014; <b>71</b>(9): 7227. <a target=xrefwindow id=d25407e1831 href="http://www.ncbi.nlm.nih.gov/pubmed/24733135">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1834 href="http://dx.doi.org/10.2146/ajhp130571">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727303300">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d25407e1847 class=n-a></a>Lipsky PE, Calabrese LH, Kavanaugh A, <i> et al.</i>: Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout. <i>Arthritis Res Ther.</i> 2014; <b>16</b>(2): R60. <a target=xrefwindow id=d25407e1858 href="http://www.ncbi.nlm.nih.gov/pubmed/24588936">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1861 href="http://dx.doi.org/10.1186/ar4497">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1865 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4060440">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d25407e1874 class=n-a></a>Krystexxa. Package Insert. Republic of Ireland, 2016.</span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d25407e1884 class=n-a></a>Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (TRIPLE). 2016. <a target=xrefwindow id=d25407e1886 href="https://clinicaltrials.gov/ct2/show/NCT02598596?term=pegloticase&amp;rank=2">Reference Source</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d25407e1895 class=n-a></a>Shen Z, Rowlings C, Kerr B, <i> et al.</i>: Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males. <i>Drug Des Devel Ther.</i> 2015; <b>9</b>: 342334. <a target=xrefwindow id=d25407e1906 href="http://www.ncbi.nlm.nih.gov/pubmed/26170627">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1909 href="http://dx.doi.org/10.2147/DDDT.S85193">Publisher Full Text </a> | <a target=xrefwindow id=d25407e1913 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4494180">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d25407e1922 class=n-a></a>Saag KG, Adler S, Bhakta N, <i> et al.</i>: Lesinurad, a Novel Selective Uric Acid Reabsorption Inhibitor, in Two Phase III Clinical Trials: Combination Study of Lesinurad in Allopurinol Standard of Care Inadequate Responders (CLEAR 1 and 2). <i>2014 ACR/ARHP Annual Meeting</i>. 2014. <a target=xrefwindow id=d25407e1930 href="http://acrabstracts.org/abstract/lesinurad-a-novel-selective-uric-acid-reabsorption-inhibitor-in-two-phase-iii-clinical-trials-combination-study-of-lesinurad-in-allopurinol-standard-of-care-inadequate-responders-clear-1-and-2/">Reference Source</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d25407e1939 class=n-a></a>Dalbeth N, Jones G, Terkeltaub R, <i> et al.</i>: SAT0329 Lesinurad, A Novel Selective Uric Acid Reabsorption Inhibitor, in Combination with Febuxostat, in Patients with Tophaceous Gout: the Crystal Phase III Clinical Trial. <i>EULAR Annual Meeting: Annals of the Rheumatic Diseases</i>. 2015; <b>74</b>(Suppl 2): 778. <a target=xrefwindow id=d25407e1950 href="http://dx.doi.org/10.1136/annrheumdis-2015-eular.2182">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d25407e1959 class=n-a></a>Tausche AK, Alten RE, Dalbeth N, <i> et al.</i>: SAT0307 Lesinurad monotherapy in gout patients intolerant to xanthine oxidase inhibitors (LIGHT): a randomized, double-blind, placebo-controlled, 6-month phase III clinical trial. <i>Ann Rheum Dis.</i> 2015; <b>74</b>(Suppl 2): 769. <a target=xrefwindow id=d25407e1970 href="http://dx.doi.org/10.1136/annrheumdis-2015-eular.2090">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727303301"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e1979 class=n-a></a>Edwards NL, So A: Emerging therapies for gout. <i>Rheum Dis Clin North Am.</i> 2014; <b>40</b>(2): 37587. <a target=xrefwindow id=d25407e1987 href="http://www.ncbi.nlm.nih.gov/pubmed/24703353">PubMed Abstract </a> | <a target=xrefwindow id=d25407e1990 href="http://dx.doi.org/10.1016/j.rdc.2014.01.013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727303301">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726225272"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e2004 class=n-a></a>Poiley J, Steinberg AS, Choi YJ, <i> et al.</i>: A Randomized, Double-Blind, Active- and Placebo-Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(8): 202734. <a target=xrefwindow id=d25407e2015 href="http://www.ncbi.nlm.nih.gov/pubmed/26989892">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2018 href="http://dx.doi.org/10.1002/art.39684">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2022 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5129473">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726225272">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d25407e2035 class=n-a></a>Khanna D, Fitzgerald JD, Khanna PP, <i> et al.</i>: 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. <i>Arthritis Care Res (Hoboken).</i> 2012; <b>64</b>(10): 143146. <a target=xrefwindow id=d25407e2046 href="http://www.ncbi.nlm.nih.gov/pubmed/23024028">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2049 href="http://dx.doi.org/10.1002/acr.21772">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2053 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3683400">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726579750"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e2062 class=n-a></a>Richette P, Doherty M, Pascual E, <i> et al.</i>: 2016 updated EULAR evidence-based recommendations for the management of gout. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(1): 2942. <a target=xrefwindow id=d25407e2073 href="http://www.ncbi.nlm.nih.gov/pubmed/27457514">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2076 href="http://dx.doi.org/10.1136/annrheumdis-2016-209707">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726579750">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d25407e2089 class=n-a></a>Howard RG, Pillinger MH, Gyftopoulos S, <i> et al.</i>: Reproducibility of musculoskeletal ultrasound for determining monosodium urate deposition: concordance between readers. <i>Arthritis Care Res (Hoboken).</i> 2011; <b>63</b>(10): 145662. <a target=xrefwindow id=d25407e2100 href="http://www.ncbi.nlm.nih.gov/pubmed/21702086">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2103 href="http://dx.doi.org/10.1002/acr.20527">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2107 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3183112">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d25407e2116 class=n-a></a>Richette P, Perez-Ruiz F: Serum uric acid and metabolic risk. <i>Curr Med Res Opin.</i> 2013; <b>29</b>(Suppl 3): 915. <a target=xrefwindow id=d25407e2124 href="http://www.ncbi.nlm.nih.gov/pubmed/23611367">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2127 href="http://dx.doi.org/10.1185/03007995.2013.790801">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d25407e2136 class=n-a></a>Krishnan E: Reduced glomerular function and prevalence of gout: NHANES 200910. <i>PLoS One.</i> 2012; <b>7</b>(11): e50046. <a target=xrefwindow id=d25407e2144 href="http://www.ncbi.nlm.nih.gov/pubmed/23209642">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2147 href="http://dx.doi.org/10.1371/journal.pone.0050046">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2150 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3507834">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718323245"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e2160 class=n-a></a>Dubreuil M, Zhu Y, Zhang Y, <i> et al.</i>: Allopurinol initiation and all-cause mortality in the general population. <i>Ann Rheum Dis.</i> 2015; <b>74</b>(7): 136872. <a target=xrefwindow id=d25407e2171 href="http://www.ncbi.nlm.nih.gov/pubmed/24665118">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2174 href="http://dx.doi.org/10.1136/annrheumdis-2014-205269">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2178 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4222989">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718323245">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d25407e2191 class=n-a></a>Qaseem A, Harris RP, Forciea MA: Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians. <i>Ann Intern Med.</i> 2017; <b>166</b>(1): 5868. <a target=xrefwindow id=d25407e2199 href="http://www.ncbi.nlm.nih.gov/pubmed/27802508">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2202 href="http://dx.doi.org/10.7326/M16-0570">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1088014"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e2211 class=n-a></a>Hung SI, Chung WH, Liou LB, <i> et al.</i>: HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. <i>Proc Natl Acad Sci U S A.</i> 2005; <b>102</b>(11): 41349. <a target=xrefwindow id=d25407e2222 href="http://www.ncbi.nlm.nih.gov/pubmed/15743917">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2225 href="http://dx.doi.org/10.1073/pnas.0409500102">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2229 href="http://www.ncbi.nlm.nih.gov/pmc/articles/554812">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1088014">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d25407e2242 class=n-a></a>Tassaneeyakul W, Jantararoungtong T, Chen P, <i> et al.</i>: Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. <i>Pharmacogenet Genomics.</i> 2009; <b>19</b>(9): 7049. <a target=xrefwindow id=d25407e2253 href="http://www.ncbi.nlm.nih.gov/pubmed/19696695">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2256 href="http://dx.doi.org/10.1097/FPC.0b013e328330a3b8">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d25407e2265 class=n-a></a>Kang HR, Jee YK, Kim YS, <i> et al.</i>: Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans. <i>Pharmacogenet Genomics.</i> 2011; <b>21</b>(5): 3037. <a target=xrefwindow id=d25407e2276 href="http://www.ncbi.nlm.nih.gov/pubmed/21301380">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2279 href="http://dx.doi.org/10.1097/FPC.0b013e32834282b8">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d25407e2288 class=n-a></a>Hershfield MS, Callaghan JT, Tassaneeyakul W, <i> et al.</i>: Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing. <i>Clin Pharmacol Ther.</i> 2013; <b>93</b>(2): 1538. <a target=xrefwindow id=d25407e2299 href="http://www.ncbi.nlm.nih.gov/pubmed/23232549">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2302 href="http://dx.doi.org/10.1038/clpt.2012.209">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2306 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3564416">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725334891"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e2316 class=n-a></a>Park DJ, Kang JH, Lee JW, <i> et al.</i>: Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea. <i>Arthritis Care Res (Hoboken).</i> 2015; <b>67</b>(2): 2807. <a target=xrefwindow id=d25407e2327 href="http://www.ncbi.nlm.nih.gov/pubmed/25047754">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2330 href="http://dx.doi.org/10.1002/acr.22409">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725334891">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727303303"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e2343 class=n-a></a>Lu N, Rai SK, Terkeltaub R, <i> et al.</i>: Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States. <i>Semin Arthritis Rheum.</i> 2016; <b>46</b>(2): 2538. <a target=xrefwindow id=d25407e2354 href="http://www.ncbi.nlm.nih.gov/pubmed/27217070">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2357 href="http://dx.doi.org/10.1016/j.semarthrit.2016.03.014">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2361 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5035554">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727303303">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d25407e2374 class=n-a></a>Stamp LK, Taylor WJ, Jones PB, <i> et al.</i>: Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. <i>Arthritis Rheum.</i> 2012; <b>64</b>(8): 252936. <a target=xrefwindow id=d25407e2385 href="http://www.ncbi.nlm.nih.gov/pubmed/22488501">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2388 href="http://dx.doi.org/10.1002/art.34488">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d25407e2397 class=n-a></a>Keenan RT, Pillinger MH: Hyperuricemia, gout, and cardiovascular disease--an important muddle. <i>Bull NYU Hosp Jt Dis.</i> 2009; <b>67</b>(3): 28590. <a target=xrefwindow id=d25407e2405 href="http://www.ncbi.nlm.nih.gov/pubmed/19852752">PubMed Abstract </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d25407e2414 class=n-a></a>Ohno I: Relationship between hyperuricemia and chronic kidney disease. <i>Nucleosides Nucleotides Nucleic Acids.</i> 2011; <b>30</b>(12): 103944. <a target=xrefwindow id=d25407e2422 href="http://www.ncbi.nlm.nih.gov/pubmed/22132954">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2425 href="http://dx.doi.org/10.1080/15257770.2011.611484">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d25407e2434 class=n-a></a>Wei L, Mackenzie IS, Chen Y, <i> et al.</i>: Impact of allopurinol use on urate concentration and cardiovascular outcome. <i>Br J Clin Pharmacol.</i> 2011; <b>71</b>(4): 6007. <a target=xrefwindow id=d25407e2445 href="http://www.ncbi.nlm.nih.gov/pubmed/21395653">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2448 href="http://dx.doi.org/10.1111/j.1365-2125.2010.03887.x">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2452 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3080649">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725951552"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e2462 class=n-a></a>Larsen KS, Pottegrd A, Lindegaard HM, <i> et al.</i>: Effect of Allopurinol on Cardiovascular Outcomes in Hyperuricemic Patients: A Cohort Study. <i>Am J Med.</i> 2016; <b>129</b>(3): 299306.e2. <a target=xrefwindow id=d25407e2473 href="http://www.ncbi.nlm.nih.gov/pubmed/26589484">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2476 href="http://dx.doi.org/10.1016/j.amjmed.2015.11.003">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725951552">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725317073"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e2489 class=n-a></a>Goicoechea M, Garcia de Vinuesa S, Verdalles U, <i> et al.</i>: Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. <i>Am J Kidney Dis.</i> 2015; <b>65</b>(4): 5439. <a target=xrefwindow id=d25407e2500 href="http://www.ncbi.nlm.nih.gov/pubmed/25595565">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2503 href="http://dx.doi.org/10.1053/j.ajkd.2014.11.016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725317073">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725388405"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e2516 class=n-a></a>Lu N, Dubreuil M, Zhang Y, <i> et al.</i>: Gout and the risk of Alzheimers disease: a population-based, BMI-matched cohort study. <i>Ann Rheum Dis.</i> 2016; <b>75</b>(3): 54751. <a target=xrefwindow id=d25407e2527 href="http://www.ncbi.nlm.nih.gov/pubmed/25739830">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2530 href="http://dx.doi.org/10.1136/annrheumdis-2014-206917">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2534 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4560667">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725388405">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d25407e2547 class=n-a></a>Sotgiu S, Pugliatti M, Sanna A, <i> et al.</i>: Serum uric acid and multiple sclerosis. <i>Neurol Sci.</i> 2002; <b>23</b>(4): 1838. <a target=xrefwindow id=d25407e2558 href="http://www.ncbi.nlm.nih.gov/pubmed/12536287">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2561 href="http://dx.doi.org/10.1007/s100720200059">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725395062"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e2570 class=n-a></a>Pakpoor J, Seminog OO, Ramagopalan SV, <i> et al.</i>: Clinical associations between gout and multiple sclerosis, Parkinsons disease and motor neuron disease: record-linkage studies. <i>BMC Neurol.</i> 2015; <b>15</b>: 16. <a target=xrefwindow id=d25407e2581 href="http://www.ncbi.nlm.nih.gov/pubmed/25884318">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2584 href="http://dx.doi.org/10.1186/s12883-015-0273-9">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2588 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4355134">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725395062">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d25407e2601 class=n-a></a>Alonso A, Sovell KA: Gout, hyperuricemia, and Parkinsons disease: a protective effect? <i>Curr Rheumatol Rep.</i> 2010; <b>12</b>(2): 14955. <a target=xrefwindow id=d25407e2609 href="http://www.ncbi.nlm.nih.gov/pubmed/20425025">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2612 href="http://dx.doi.org/10.1007/s11926-010-0083-4">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d25407e2622 class=n-a></a>Auinger P, Kieburtz K, McDermott MP: The relationship between uric acid levels and Huntingtons disease progression. <i>Mov Disord.</i> 2010; <b>25</b>(2): 2248. <a target=xrefwindow id=d25407e2630 href="http://www.ncbi.nlm.nih.gov/pubmed/20063429">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2633 href="http://dx.doi.org/10.1002/mds.22907">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2636 href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831113">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718343964"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25407e2645 class=n-a></a>Chen X, Guo X, Huang R, <i> et al.</i>: Serum uric acid levels in patients with Alzheimers disease: a meta-analysis. <i>PLoS One.</i> 2014; <b>9</b>(4): e94084. <a target=xrefwindow id=d25407e2656 href="http://www.ncbi.nlm.nih.gov/pubmed/24714617">PubMed Abstract </a> | <a target=xrefwindow id=d25407e2659 href="http://dx.doi.org/10.1371/journal.pone.0094084">Publisher Full Text </a> | <a target=xrefwindow id=d25407e2663 href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979756">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718343964">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 10 Mar 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-247/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-247/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> The Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, NY, USA<br/> <sup>2</sup> The School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-247/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 10 Mar 2017, 6:247 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.9402.1">https://doi.org/10.12688/f1000research.9402.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2017 Igel TF <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=10126 data-id=9402 data-downloads="" data-views="" data-scholar="10.12688/f1000research.9402.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-247/v1/pdf?article_uuid=0eb00956-c4cc-4a59-8189-7cca07973af7" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.9402.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Igel TF, Krasnokutsky S and Pillinger MH. Recent advances in understanding and managing gout [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):247 (<a href="https://doi.org/10.12688/f1000research.9402.1" target=_blank>https://doi.org/10.12688/f1000research.9402.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=9402 id=mobile-track-article-signin-9402 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/9402?target=/articles/6-247/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=10126 /> <input name=articleId type=hidden value=9402 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>N. Lawrence Edwards</strong>, Department of Medicine, University of Florida College of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Richard Day</strong>, Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital, Australia; School of Medical Sciences, University of New South Wales, Australia </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 10 Mar 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-247/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-247/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=19888-19541></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=19887-19540></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-247/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>10 Mar 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>N. Lawrence Edwards</strong>, Department of Medicine, University of Florida College of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Richard Day</strong>, Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital, Australia; School of Medical Sciences, University of New South Wales, Australia </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-247/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-247/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding and managing...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-247/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-247/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-247/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Igel TF et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-247/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-247",
            templates : {
                twitter : "Recent advances in understanding and managing gout. Igel TF et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-247/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding and managing gout", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding and managing gout", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/9402/10126")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "10126");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "19540": 0,
                           "19541": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "7aa9bbf5-5591-4a9c-9b2e-36db9228ca77";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-247.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-247.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-247.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-247.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-247.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>